The scientific journal Nutrients published a study in 2025 dedicated to the benefits of epigallocatechin gallate (EGCG), a natural component found in green tea, on liver function.
This study was conducted by researchers from the School of Chemistry and Environmental Sciences (Xiangnan University), the School of Life and Health Sciences (Hunan University of Science and Technology), and the Key Laboratory of Tea Science of the Ministry of Education (Hunan Agricultural University).
This review specifically highlights the fundamental role of EGCG in liver diseases, focusing on viral hepatitis, autoimmune hepatitis, hepatic steatosis, and hepatocellular carcinoma.
The study concludes that EGCG not only inhibits the entry and replication of hepatitis B and C viruses in hepatocytes but also mitigates hepatocyte damage caused by hepatitis-induced inflammation.
Access the full text of the article at the following link:
https://www.mdpi.com/2072-6643/17/7/1101/pdf?version=1742548394
Zhou, F.; Deng, S.; Luo, Y.; Liu, Z.; Liu, C. Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver. Nutrients 2025, 17, 1101. https://doi.org/10.3390/nu17071101
You can find more information about articles dedicated to the benefits of tea published in scientific journals in our “Benefits of Tea” section.